Characterization of DNA hydroxymethylation profile in cervical cancer

References

• Plummer M, de Martel C, Vignat J, et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. The Lancet Global Health.2016; 4:e609–16.
   PubMed Web of Science ®Google Scholar
• Cutts FT, Franceschi S, Goldie S, et al. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ. 2007;85:719–726.
   PubMed Web of Science ®Google Scholar
• Zhao YB, Wang JH, Chen XX, et al. Values of three different preoperative regimens in comprehensive treatment for young patients with stage Ib2 cervical cancer. Asian Pacific Journal of Cancer Prevention: APJCP.2012; 13:1487–1489.
   PubMedGoogle Scholar
• Feng C, Dong J, Chang W, et al. The progress of methylation regulation in gene expression of cervical cancer. .2018;2018:1.
   Google Scholar
• Koh KP, Yabuuchi A, Rao S, et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell. 2011;8:200–213.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang X, Clark E, et al. TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine. Cell Res. 2010;20:1390–1393.
   PubMed Web of Science ®Google Scholar
• Wu SC, Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol. 2010;11:607–620.
   PubMed Web of Science ®Google Scholar
• Kantidze OL, Razin SV. 5-hydroxymethylcytosine in DNA repair: a new player or a red herring? Cell Cycle. 2017;16:1499–1501.
   PubMed Web of Science ®Google Scholar
• Li X, Cai Y. Methylation-based classification of cervical squamous cell carcinoma into two new subclasses differing in immune-related gene expression. IJMS. 2018;19:3607.
   Web of Science ®Google Scholar
• Yuan LY, Qin X, Li L, et al. The transcriptome profiles and methylation status revealed the potential cancer-related lncRNAs in patients with cervical cancer. J Cell Physiol. 2018;234:9756–9763.
   PubMed Web of Science ®Google Scholar
• van Leeuwen RW, Ostrbenk A, Poljak M, et al. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort. Int J Cancer. 2018;144:746–754.
   PubMed Web of Science ®Google Scholar
• Rogeri CD, Silveira HCS, Causin RL, et al. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer. Gynecologic Oncology.2018;150:545–551.
   PubMed Web of Science ®Google Scholar
• Zhang LY, Han CS, Li PL, et al. 5-Hydroxymethylcytosine expression is associated with poor survival in cervical squamous cell carcinoma. Jpn J Clin Oncol. 2016;46:427–434.
   PubMed Web of Science ®Google Scholar
• Bhat S, Kabekkodu SP, Varghese VK, et al. Aberrant gene-specific DNA methylation signature analysis in cervical cancer. Tumour Biol. 2017;39:1010428317694573.
   Google Scholar
• Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–104.
   PubMed Web of Science ®Google Scholar
• Zhong J, Wei X. Characterization of DNA hydroxymethylation in hypothalamus of elderly mice with postoperative cognitive dysfunction. bioRxiv 2018;488007.
   Google Scholar
• Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–2120.
   PubMed Web of Science ®Google Scholar
• Andrews S. FastQC a quality control tool for high throughput sequence data. 2013.
   Google Scholar
• Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:3579.
   Web of Science ®Google Scholar
• Zhang Y, Liu T, Meyer CA, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9:R137.
   PubMed Web of Science ®Google Scholar
• Ross-Innes CS, Stark R, Teschendorff AE, et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature. 2012;481:389–393.
   PubMed Web of Science ®Google Scholar
• Zhou S, Shen Y, Zheng M, et al. DNA methylation of METTL7A gene body regulates its transcriptional level in thyroid cancer. Oncotarget. 2017;8:34652–34660.
   PubMedGoogle Scholar
• Liu N, Zhao R, Ma Y, et al. The development of epigenetics and related inhibitors for targeted drug design in cancer therapy. CTMC. 2018;18:2380–2394
   Web of Science ®Google Scholar
• Shu L, Sun W, Li L, et al. Genome-wide alteration of 5-hydroxymenthylcytosine in a mouse model of Alzheimer's disease. BMC Genomics. 2016;17:381.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Li Z, Manupipatpong S, et al. 5-Hydroxymethylcytosine alterations in the human postmortem brains of autism spectrum disorder. Hum Mol Genet. 2018;27:2955–2964.
   PubMed Web of Science ®Google Scholar